Orforglipron Impurity 3 is a chemical compound used as a pharmaceutical intermediate. It is primarily employed in the research and manufacturing of pharmaceutical products.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2212022-55-2
2,3-DICHLOROQUINOXALINE
Pharmaceutical intermediate for synthesis
(s)-1-(1-(tert-butoxycarbonyl)piperidin-4-yl)pyrrolidine-2-carboxylic acid
Pharmaceutical intermediate for peptide synthesis
3-(4-Fluorophenyl)-2-methylacrylic acid
pharmaceutical intermediate
4-Phenoxybenzoic acid
pharmaceutical intermediate
(S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one
n.a
(S)-1-(4-FLUORO-1-METHYL-1H-INDAZOL-5-YL)-3-(2-(4-FLUORO-3,5-DIMETHYLPHENYL)-4-METHYL-4,5,6,7-TETRAHYDRO-2H-PYRAZOLO[4,3-C]PYRIDIN-3-YL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE HYDROCHLORIDE
research compound
tert-butyl (4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate
ZSFBDHLLSBONMH-IBGZPJMESA-N
C[C@H]1C2=C(N(N=C2CCN1C(=O)OC(C)(C)C)C3=CC(=C(C(=C3)C)F)C)N4C=CN(C4=O)C5=C(C6=C(C=C5)N(N=C6)C)F